Precision Medicine and Novel Technology

Precision medicine aims to provide the right treatment for the right patient at the right time with treatment directed on the basis of the targetable tumoral aberrations rather than just a traditional histologic subtype. However to facilitate this approach, clinicians require patient derived samples. Prostate cancer is challenging to culture in vitro. Recent development of novel organoid in vitro culture technology has led to the development of multiple new in vitro prostate cancer cell line models. We aim to apply organoid culture technology to develop novel in vitro prostate cancer cell line models and propagate patient derived samples to allow drug testing and next generation sequencing as part of a precision medicine approach to early recurrent prostate cancer.

 

  • Invitro Organoid Technology
  • Digital Health
  • Single-Cell DNA Analysis
  • Progress and Challenges in Precision Medicine

Related Conference of Precision Medicine and Novel Technology

February 04-05, 2026

18th International Conference on Gynecology

Rome, Italy
February 25-26, 2026

15th International Conference on Herbal Medicine and Acupuncture

Aix-en-Provence, France
March 09-10, 2026

13th World Machine Learning and Deep learning Conference

Singapore City, Singapore
March 26-27, 2026

12th World Congress on Anesthesia and Critical Care

Amsterdam, Netherlands
April 20-21, 2026

47th International Summit on Human Anatomy & Physiology

Barcelona, Spain
September 14-15, 2026

6th World Medicine Congress

Rome, Italy
October 19-20, 2026

12th World Congress on Medicinal Plants and Marine Drugs

Aix-en-Provence, France

Precision Medicine and Novel Technology Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in